Menu

Duke professor-led biotech company raises $175 million to advance epigenome editing therapy clinical trials

Article |

tealstorm7f 3d ago
Duke professor-led biotech company raises $175 million to advance epigenome editing therapy clinical trials

Tune Therapeutics, a Durham biotechnology startup co-founded by a Duke professor, announced the completion of its Series B fundraising round...

Comments (0)

Newest

No comments yet.